Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors

Medicine and Dentistry

• Neoplasm 100%
• Monoclonal Antibody 100%
• T Cell Activation 100%
• T-Helper Cell 66%
• T Cell 66%
• Cytotoxic T-Cell 66%
• Glycoprotein 33%
• Ligation 33%
• Malignant Neoplasm 33%
• Immunotherapy 33%
• Sarcoma 33%
• Immune Response 33%
• Macrophage 33%
• Cell Growth 33%
• Cellular Immunity 33%
• B Cell 33%
• Antigen Presenting Cell 33%
• Tumor Necrosis Factor Receptor 33%
• Cell Activity 33%

Keyphrases

• Tumor 100%
• Monoclonal Antibody 100%
• T Cell Activation 100%
• 4-1BB 100%
• Glycoprotein 16%
• Immunogenic 16%
• Sarcoma 16%
• CD4+ T Cells 16%
• Immune Response 16%
• Human Cancer 16%
• Ligation 16%
• Antigen-presenting Cells 16%
• CD4+ 16%
• Cell Growth 16%
• CD8+ 16%
• CD8+ T Cells 16%
• Macrophages 16%
• T Cell Immune Response 16%
• Cytolytic T Cells 16%
• Tumor Selectivity 16%
• Large Tumors 16%
• Activated B Cells 16%
• TNF Receptor 1 (TNFR1) 16%
• High-affinity Ligands 16%
• 4-1BBL 16%
• P815 16%
• 4-1BB Signaling 16%

Immunology and Microbiology

• Monoclonal Antibody 100%
• T Cell Activation 100%
• T Cell 66%
• T-Helper Cell 66%
• Cytotoxic T-Cell 66%
• Glycoprotein 33%
• Immune Response 33%
• Mouse 33%
• Immunotherapy 33%
• B Cell 33%
• Macrophage 33%
• Cell Activity 33%
• Antigen-Presenting Cell 33%
• Cell Growth 33%
• Adoptive Immunity 33%
• Tumor Necrosis Factor Receptor 33%